BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 26645730)

  • 21. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanocytic Skin Neoplasms: What Lesson From Genomic Aberrations?
    Urso C
    Am J Dermatopathol; 2019 Sep; 41(9):623-629. PubMed ID: 31433323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic profile of GNAQ-mutated blue melanocytic neoplasms reveals mutations in genes linked to genomic instability and the PI3K pathway.
    Pérez-Alea M; Vivancos A; Caratú G; Matito J; Ferrer B; Hernandez-Losa J; Cortés J; Muñoz E; Garcia-Patos V; Recio JA
    Oncotarget; 2016 May; 7(19):28086-95. PubMed ID: 27057633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanoma arising in plaque-type blue nevus and dermal melanocytosis: Diagnostic and prognostic value of BAP1.
    Requena C; Traves V; Ferrandis E; Antón Almero M; García-Casado Z; Manrique-Silva E; Santos Briz Á; Escalonilla P; Nagore E
    Actas Dermosifiliogr; 2023; 114(7):636-641. PubMed ID: 37088284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agminated blue nevus with a GNAQ mutation: A case report and review of the literature.
    Eichenfield DZ; Cotter D; Thorson J; Hinds B; Sun BK
    J Cutan Pathol; 2019 Feb; 46(2):130-133. PubMed ID: 30315589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi.
    Bender RP; McGinniss MJ; Esmay P; Velazquez EF; Reimann JD
    Mod Pathol; 2013 Oct; 26(10):1320-8. PubMed ID: 23599145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 Cases.
    Hung T; Argenyi Z; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Piepkorn MW; Prieto VG; Rabkin MS; Schmidt B; Selim MA; Shea CR; Trotter MJ; Barnhill RL
    Am J Dermatopathol; 2016 Jul; 38(7):499-503. PubMed ID: 26909585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and clinico-pathologic analysis of metastatic uveal melanoma.
    Griewank KG; van de Nes J; Schilling B; Moll I; Sucker A; Kakavand H; Haydu LE; Asher M; Zimmer L; Hillen U; Thompson JF; Scolyer RA; Schadendorf D; Murali R
    Mod Pathol; 2014 Feb; 27(2):175-83. PubMed ID: 23887304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas.
    Küsters-Vandevelde HV; Creytens D; van Engen-van Grunsven AC; Jeunink M; Winnepenninckx V; Groenen PJ; Küsters B; Wesseling P; Blokx WA; Prinsen CF
    Acta Neuropathol Commun; 2016 Jan; 4():5. PubMed ID: 26769193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series.
    Aung PP; Nagarajan P; Tetzlaff MT; Curry JL; Tang G; Abdullaev Z; Pack SD; Ivan D; Prieto VG; Torres-Cabala CA
    Am J Dermatopathol; 2019 Mar; 41(3):167-179. PubMed ID: 30801340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iris and Ciliary Body Melanocytomas Are Defined by Solitary GNAQ Mutation Without Additional Oncogenic Alterations.
    Solomon DA; Ramani B; Eiger-Moscovich M; Milman T; Uludag G; Crawford JB; Phan I; Char DH; Shields CL; Eagle RC; Bastian BC; Bloomer MM; Pekmezci M
    Ophthalmology; 2022 Dec; 129(12):1429-1439. PubMed ID: 35835335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases.
    Phadke PA; Rakheja D; Le LP; Selim MA; Kapur P; Davis A; Mihm MC; Hoang MP
    Am J Surg Pathol; 2011 May; 35(5):656-69. PubMed ID: 21436676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanoma arising in association with blue nevus: a clinical and pathologic study of 24 cases and comprehensive review of the literature.
    Loghavi S; Curry JL; Torres-Cabala CA; Ivan D; Patel KP; Mehrotra M; Bassett R; Prieto VG; Tetzlaff MT
    Mod Pathol; 2014 Nov; 27(11):1468-78. PubMed ID: 24743221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
    Marušić Z; Buljan M; Busam KJ
    J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compound blue nevus: a reappraisal of the concept in the genomic era.
    Jaquemus J; Perron E; Buisson A; Ferrara G; Haddad V; de la Fouchardiere A
    Virchows Arch; 2020 Mar; 476(3):439-443. PubMed ID: 31754815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Clinical, Histopathologic, and Molecular Analysis and Long-term Follow-up of Patients With Nodal Blue Nevi.
    Colebatch AJ; Adhikari C; Diefenbach RJ; Rawson RV; Ferguson PM; Rizos H; Long GV; McCarthy SW; Thompson JF; Wilmott JS; Scolyer RA
    Am J Surg Pathol; 2022 Aug; 46(8):1048-1059. PubMed ID: 35439782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.
    Scholz SL; Möller I; Reis H; Süßkind D; van de Nes JAP; Leonardelli S; Schilling B; Livingstone E; Schimming T; Paschen A; Sucker A; Murali R; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3464-3470. PubMed ID: 28700778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blue nevi and variants: an update.
    Zembowicz A; Phadke PA
    Arch Pathol Lab Med; 2011 Mar; 135(3):327-36. PubMed ID: 21366456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.